Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antiproteinuric Efficacy of ACE Inhibitors, Selective MRAs and ACE Inhibitor/Selective MRA Combination Therapy in Diabetic Hypertensives With Microalbuminuria

NCT04143412 is registered in ClinicalTrials.gov with Beni-Suef University as lead sponsor.

NCT NCT04143412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04143412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antiproteinuric Efficacy of ACE Inhibitors, Selective MRAs and ACE Inhibitor/Selective MRA Combination Therapy in Diabetic Hypertensives With Microalbuminuria
Lead sponsor
Beni-Suef University
Phase
Phase 2
Overall status
Unknown status
Start date
February 4, 2019
Completion date
March 31, 2020
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic nephropathy type 2, microalbuminuria due to type 2 diabetes mellitus